Explore baxter.com

This global site is intended for Healthcare Professionals only. All products may not be available in all countries. Contact your local Baxter representative

Renal Care

Therapies

We deliver and support renal therapies across the continuum of care, including the innovative HDx.

Therapies
  • Acute Therapy

    Organ support and blood purification therapies are essential to improving patient outcomes in the ICU.

  • Peritoneal Dialysis

    Peritoneal Dialysis - combined with Remote Patient Management - offers the potential to improve renal patients' clinical outcomes and increase lifestyle flexibility.

  • Hemodialysis

    Hemodialysis is the predominant therapy for end-stage kidney disease, and can be delivered through multiple therapy options.

  • HDx Therapy

    HDx - also known as expanded hemodialysis - is an innovative therapy that effectively targets the removal of large middle molecules.

Products

Learn more about Baxter’s key products for Renal Care – across the continuum of care.

Data & Insights

Groundbreaking research and inspirational patient stories.

  • Clinical Data

    Explore the research enabling innovative Renal Care.

  • Stories

    Patients’ journeys inspire our work and drive our commitment.

  • Resource Library

    Access resources for Baxter’s broader Renal Care portfolio.

Clinical Data

Clinical research lies at the heart of who we are. Baxter uses scientific evidence systematically, and transparently, to inform the development of new and state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Baxter. 

clinical-data-module-image2.png
Clinical Data – PD •

Remote Patient Management technology enhances the experience of Automated Peritoneal Dialysis

The flexibility that Peritoneal Dialysis (PD) offers renal patients allows them to maintain their lifestyle and independence. When Automated PD is combined with Remote Patient Monitoring, the flexibility is further enhanced and is associated with the potential to improve clinical outcomes and adherence.

Read More

A Focus on Clinical Research

HDx

Randomized controlled trial of medium cut-off versus high-flux dialyzers on quality of life outcomes in maintenance hemodialysis patients.

View resource
HDx

Rationale for Medium Cutoff Membranes in COVID-19 Patients Requiring Renal Replacement Therapy

View resource
HDx

Removal of middle molecules with medium cutoff dialyzer in patients on short frequent hemodialysis

View resource
HDx

Can better efficacy of middle weight molecules removal in dialysis patients treated with medium cut-off membranes predict superiority over conventional high flux dialysers?

View resource
PD

Evaluating a remote patient monitoring program for automated peritoneal dialysis - Ariza J, et al.

View resource
HDx

Experience of using haemodialysis with medium cut-off dialyser in cast nephropathy

View resource
HDx

Effects of Expanded Hemodialysis Therapy on Clinical Outcomes

View resource
HDx

Evaluation of the influence of the surface membrane and blood flow in medium «cut-off» (MCO) dialyzers

View resource
HDx

High-Flux versus High-Retention-Onset Membranes: In vivo Small and Middle Molecules Kinetics in Convective Dialysis Modalities - Cordeiro ISF et al.

View resource
HDx

Intradialytic kinetics of middle molecules during hemodialysis and hemodiafiltration

View resource
HDx

Large uremic toxins: an unsolved problem in end-stage kidney disease - Wolley MJ and Hutchison CA.

View resource
HDx

Long-term effect of medium cut-off dialyzer on middle uremic toxins and cell-free hemoglobin - Cho N-J et al.

View resource